Therapeutic Advances and Considerations for Treatment Selection in High-Risk AML episode artwork

EPISODE · Apr 13, 2022 · 25 MIN

Therapeutic Advances and Considerations for Treatment Selection in High-Risk AML

from Oncology Learning Network · host HMP Global

Guenther Koehne, MD, PhD, interviews Richard Stone, MD; Robert Soiffer, MD; and Siddhartha Mukherjee, MD, on recent therapeutic advances for hematologic malignancies with a focus on considerations for treatment selection in high-risk AML.

Episode metadata supplied by the publisher feed · Published Apr 13, 2022

Embed this episode

Ready to play

Therapeutic Advances and Considerations for Treatment Selection in High-Risk AML

0:00 25:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Learning Network?

This episode is 25 minutes long.

When was this Oncology Learning Network episode published?

This episode was published on April 13, 2022.

Can I download this Oncology Learning Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!